Literature DB >> 12088454

Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis, and expression of p53, CD44, bcl-2.

Norman J Carr1, Theresa S Emory, Leslie H Sobin.   

Abstract

CONTEXT: Carcinomas of the appendix are usually well-differentiated mucinous adenocarcinomas that tend to produce pseudomyxoma peritonei and do not show metastatic spread until late in the disease process. In contrast, adenocarcinomas of the colon and rectum rarely result in pseudomyxoma peritonei and frequently metastasize, even if mucinous and well differentiated. These differences in behavior may be reflected by differences at the molecular level.
OBJECTIVES: To examine adenocarcinomas and their precursor lesions (adenomas) of the appendix and colorectum and to determine whether differences exist in the numbers of proliferating and apoptotic cells or in expression of p53, bcl-2, and the standard form of CD44 (CD44s).
DESIGN: Retrospective analysis of surgical specimens.
SETTING: Multicenter study. PATIENTS: Individuals treated surgically for tumors of the appendix or colorectum.
INTERVENTIONS: Sections were cut from formalin-fixed surgical specimens and immunohistochemical tests were performed for Ki-67 (as a marker of proliferating cells), M30 (as a marker of apoptotic cells), p53, CD44s, and bcl-2. MAIN OUTCOME MEASURES: Expression of Ki-67, M30, p53, CD44s, and bcl-2 in tumor cells.
RESULTS: The appendiceal adenomas showed significantly lower Ki-67 counts, p53 expression, and bcl-2 expression. When compared with adenocarcinomas of the colorectum in general (mucinous and nonmucinous), the appendiceal adenocarcinomas showed significantly lower Ki-67 counts, M30 counts, and CD44s expression. However, when the analysis was confined to well-differentiated mucinous adenocarcinomas, only the M30 count was significantly different.
CONCLUSIONS: The lower proliferative and apoptotic activity of appendiceal carcinomas and the lower CD44s expression are in keeping with their more indolent behavior compared with adenocarcinomas of the colorectum. However, when only the subset of well-differentiated mucinous adenocarcinomas was compared, only the apoptotic activity was different, suggesting that the other differences were related to the morphologic structure of the lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088454     DOI: 10.5858/2002-126-0837-ENOTAA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Adenocarcinoma Ex-goblet Cell Carcinoid of the Appendix: a Case Report and Overview of the Disease.

Authors:  Uroosa Ibrahim; Gautam Valecha; Gwenalyn Garcia; Amina Saqib; Monika Wrzolek; Meekoo Dhar
Journal:  J Gastrointest Cancer       Date:  2018-12

2.  Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy.

Authors:  Lawson Ung; Terence C Chua; Morris David L
Journal:  J Cancer Res Clin Oncol       Date:  2013-11       Impact factor: 4.553

3.  Primary appendiceal mucinous adenocarcinoma.

Authors:  Prativa Kumari Behera; Pramod Kumar Rath; Rabiratna Panda; Sanghamitra Satpathi; Rajan Behera
Journal:  Indian J Surg       Date:  2010-12-03       Impact factor: 0.656

4.  Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience.

Authors:  Vignesh Narasimhan; Kasmira Wilson; Maneka Britto; Satish Warrier; A Craig Lynch; Michael Michael; Jeanne Tie; Tim Akhurst; Catherine Mitchell; Robert Ramsay; Alexander Heriot
Journal:  J Gastrointest Surg       Date:  2019-05-14       Impact factor: 3.452

5.  Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.

Authors:  Tommaso Cioppa; Marco Vaira; Camilla Bing; Silvia D'Amico; Alessandro Bruscino; Michele De Simone
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

6.  Updated staging and patient outcomes in low-grade appendiceal mucinous neoplasms.

Authors:  Samuel J Ballentine; Jacquelyn Carr; Eliahu Y Bekhor; Umut Sarpel; Alexandros D Polydorides
Journal:  Mod Pathol       Date:  2020-07-29       Impact factor: 7.842

7.  Clinical Association of CD44 Expression with Proliferative Activity and Apoptotic State in Egyptian Patients Suffering from Ulcerative Colitis and Colorectal Carcinoma.

Authors:  Hoda El-Emshaty; Doaa Hassan; Mohamed El-Hemaly; Hisham Ismail
Journal:  Asian Pac J Cancer Prev       Date:  2021-11-01

8.  Detection of Cancer Stem Cells in Colorectal Cancer: Histopathological and Immunohistochemical Study.

Authors:  Nour El Hoda S Ismaiel; Walid M Sharaf; Dina O Helmy; Mona M Zaki; Manal A Badawi; Ahmed S A Soliman
Journal:  Open Access Maced J Med Sci       Date:  2016-12-07

9.  Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review.

Authors:  Yingbo Gong; Xin Wang; Zhi Zhu
Journal:  Gastroenterol Res Pract       Date:  2020-07-03       Impact factor: 2.260

10.  Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms.

Authors:  G Nishikawa; S Sekine; R Ogawa; A Matsubara; T Mori; H Taniguchi; R Kushima; N Hiraoka; K Tsuta; H Tsuda; Y Kanai
Journal:  Br J Cancer       Date:  2013-02-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.